Yali Wang - Search Results

Year	Number of Results
2003	3
2004	3
2005	4
2006	10
2007	8
2008	9
2009	11
2010	21
2011	13
2012	15
2013	17
2014	31
2015	44
2016	48
2017	48
2018	46
2019	73
2020	130
2021	128
2022	112
2023	106
2024	45

1

Approved HIV reverse transcriptase inhibitors in the past decade.

Li G, Wang Y, De Clercq E. Li G, et al. Among authors: wang y. Acta Pharm Sin B. 2022 Apr;12(4):1567-1590. doi: 10.1016/j.apsb.2021.11.009. Epub 2021 Nov 16. Acta Pharm Sin B. 2022. PMID: 35847492 Free PMC article. Review.

2

Pathways and assays for DNA double-strand break repair by homologous recombination.

Li J, Sun H, Huang Y, Wang Y, Liu Y, Chen X. Li J, et al. Among authors: wang y. Acta Biochim Biophys Sin (Shanghai). 2019 Sep 6;51(9):879-889. doi: 10.1093/abbs/gmz076. Acta Biochim Biophys Sin (Shanghai). 2019. PMID: 31294447 Free article. Review.

3

RAD21 amplification epigenetically suppresses interferon signaling to promote immune evasion in ovarian cancer.

Deng P, Wang Z, Chen J, Liu S, Yao X, Liu S, Liu L, Yu Z, Huang Y, Xiong Z, Xiao R, Gao J, Liang W, Chen J, Liu H, Hong JH, Chan JY, Guan P, Chen J, Wang Y, Yin J, Li J, Zheng M, Zhang C, Zhou P, Kang T, Teh BT, Yu Q, Zuo Z, Jiang Q, Liu J, Xiong Y, Xia X, Tan J. Deng P, et al. Among authors: wang y. J Clin Invest. 2022 Nov 15;132(22):e159628. doi: 10.1172/JCI159628. J Clin Invest. 2022. PMID: 36201246 Free PMC article.

4

Proteomic characterization of epithelial ovarian cancer delineates molecular signatures and therapeutic targets in distinct histological subtypes.

Gong TT, Guo S, Liu FH, Huo YL, Zhang M, Yan S, Zhou HX, Pan X, Wang XY, Xu HL, Kang Y, Li YZ, Qin X, Xiao Q, Huang DH, Li XY, Zhao YY, Zhao XX, Wang YL, Ma XX, Gao S, Zhao YH, Ning SW, Wu QJ. Gong TT, et al. Nat Commun. 2023 Nov 28;14(1):7802. doi: 10.1038/s41467-023-43282-3. Nat Commun. 2023. PMID: 38016970 Free PMC article.

5

Inhibition of the PLK1-Coupled Cell Cycle Machinery Overcomes Resistance to Oxaliplatin in Colorectal Cancer.

Yu Z, Deng P, Chen Y, Liu S, Chen J, Yang Z, Chen J, Fan X, Wang P, Cai Z, Wang Y, Hu P, Lin D, Xiao R, Zou Y, Huang Y, Yu Q, Lan P, Tan J, Wu X. Yu Z, et al. Among authors: wang y. Adv Sci (Weinh). 2021 Dec;8(23):e2100759. doi: 10.1002/advs.202100759. Epub 2021 Oct 28. Adv Sci (Weinh). 2021. PMID: 34881526 Free PMC article.

6

EZH2 mediated metabolic rewiring promotes tumor growth independently of histone methyltransferase activity in ovarian cancer.

Chen J, Hong JH, Huang Y, Liu S, Yin J, Deng P, Sun Y, Yu Z, Zeng X, Xiao R, Chan JY, Guan P, Wang Y, Wang P, Liu L, Wen S, Yu Q, Ong CK, Teh BT, Xiong Y, Tan J. Chen J, et al. Among authors: wang y. Mol Cancer. 2023 May 20;22(1):85. doi: 10.1186/s12943-023-01786-y. Mol Cancer. 2023. PMID: 37210576 Free PMC article.

7

Construction and Validation of a Reliable Disulfidptosis-Related LncRNAs Signature of the Subtype, Prognostic, and Immune Landscape in Colon Cancer.

Dong X, Liao P, Liu X, Yang Z, Wang Y, Zhong W, Wang B. Dong X, et al. Among authors: wang y. Int J Mol Sci. 2023 Aug 18;24(16):12915. doi: 10.3390/ijms241612915. Int J Mol Sci. 2023. PMID: 37629096 Free PMC article.

8

Human umbilical cord blood-derived MSCs trans-differentiate into endometrial cells and regulate Th17/Treg balance through NF-κB signaling in rabbit intrauterine adhesions endometrium.

Hua Q, Zhang Y, Li H, Li H, Jin R, Li L, Xiang Y, Tian M, Wang J, Sun L, Wang Y. Hua Q, et al. Among authors: wang y. Stem Cell Res Ther. 2022 Jul 15;13(1):301. doi: 10.1186/s13287-022-02990-1. Stem Cell Res Ther. 2022. PMID: 35841027 Free PMC article.

9

The role of IL-17 in acute kidney injury.

Wang Y, Zhang Y, Shou S, Jin H. Wang Y, et al. Int Immunopharmacol. 2023 Jun;119:110307. doi: 10.1016/j.intimp.2023.110307. Epub 2023 May 12. Int Immunopharmacol. 2023. PMID: 37182383 Free article. Review.

10

Circ-RAPGEF5 promotes intrahepatic cholangiocarcinoma progression by stabilizing SAE1 to facilitate SUMOylation.

Zheng J, Wang Y, Tao L, Cai J, Shen Z, Liu Y, Pan H, Li S, Ruan Y, Chen T, Ye Z, Lin K, Sun Y, Xu J, Liang X. Zheng J, et al. Among authors: wang y. J Exp Clin Cancer Res. 2023 Sep 13;42(1):239. doi: 10.1186/s13046-023-02813-y. J Exp Clin Cancer Res. 2023. PMID: 37705041 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

833 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

833 results

Results by year